NASDAQ: PYPD Corporate Presentation
August 2025
PolyPid Overview
Polymer-Lipid Encapsulation matriX (PLEX) Platform
granted and pending patents(1)
Pre-NDA
Lead Product D-PLEX in
stage biopharma company
Unique LOCAL Prolonged Delivery of APIs
Phase 3 trial
OncoPLEX Next Big Opportunity for Solid Tumors
100
employees(1)
Global: Petach Tikva, Israel
US: New Jersey
NASDAQ: PYPD3
1 As of August '25
Robust Pipeline with Multiple Near- and Longer-Term Inflection Points
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |